Udvalget for Veterinærlægemidler (CVMP) konkluderede, at fordelene ved Equilis Te er større end risiciene til immunisering af heste, der er seks måneder gamle eller derover, mod stivkrampe for at forebygge dødelighed.
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Equilis Te exceeded the risks for the immunisation of horses from six months of age against tetanus to prevent mortality.